These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 8093813)
1. The initiation-promotion-progression model of rat hepatocarcinogenesis. Dragan YP; Sargent L; Xu YD; Xu YH; Pitot HC Proc Soc Exp Biol Med; 1993 Jan; 202(1):16-24. PubMed ID: 8093813 [TBL] [Abstract][Full Text] [Related]
2. Karyotypic changes in a multistage model of chemical hepatocarcinogenesis in the rat. Sargent L; Dragan Y; Xu YH; Sattler G; Wiley J; Pitot HC Cancer Res; 1996 Jul; 56(13):2985-91. PubMed ID: 8674052 [TBL] [Abstract][Full Text] [Related]
3. Quantitative stereological studies of a 'selection' protocol of hepatocarcinogenesis following initiation in neonatal male and female rats. Dragan YP; Campbell HA; Xu XH; Pitot HC Carcinogenesis; 1997 Jan; 18(1):149-58. PubMed ID: 9054601 [TBL] [Abstract][Full Text] [Related]
4. Incorporation of bromodeoxyuridine in glutathione S-transferase-positive hepatocytes during rat multistage hepatocarcinogenesis. Dragan YP; Hully J; Crow R; Mass M; Pitot HC Carcinogenesis; 1994 Sep; 15(9):1939-47. PubMed ID: 7923588 [TBL] [Abstract][Full Text] [Related]
5. Reversible alteration in the expression of the gap junctional protein connexin 32 during tumor promotion in rat liver and its role during cell proliferation. Neveu MJ; Hully JR; Paul DL; Pitot HC Cancer Commun; 1990; 2(1):21-31. PubMed ID: 1973356 [TBL] [Abstract][Full Text] [Related]
6. Quantitative stereological analysis of the effects of age and sex on multistage hepatocarcinogenesis in the rat by use of four cytochemical markers. Xu YH; Campbell HA; Sattler GL; Hendrich S; Maronpot R; Sato K; Pitot HC Cancer Res; 1990 Feb; 50(3):472-9. PubMed ID: 1967547 [TBL] [Abstract][Full Text] [Related]
7. The quantitative analysis and stability of histochemical markers of altered hepatic foci in rat liver following initiation by diethylnitrosamine administration and promotion with phenobarbital. Goldsworthy TL; Pitot HC Carcinogenesis; 1985 Sep; 6(9):1261-9. PubMed ID: 2863007 [TBL] [Abstract][Full Text] [Related]
8. Characterization of the promotion of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the female rat. Dragan YP; Xu XH; Goldsworthy TL; Campbell HA; Maronpot RR; Pitot HC Carcinogenesis; 1992 Aug; 13(8):1389-95. PubMed ID: 1354083 [TBL] [Abstract][Full Text] [Related]
9. The effect of the dose of diethylnitrosamine on the initiation of altered hepatic foci in neonatal female rats. Dragan YP; Xu YH; Pitot HC Carcinogenesis; 1993 Mar; 14(3):385-91. PubMed ID: 8095861 [TBL] [Abstract][Full Text] [Related]
10. Quantitative stereologic study of the effects of varying the time between initiation and promotion on four histochemical markers in rat liver during hepatocarcinogenesis. Xu YH; Maronpot R; Pitot HC Carcinogenesis; 1990 Feb; 11(2):267-72. PubMed ID: 1967985 [TBL] [Abstract][Full Text] [Related]
11. Quantitation of multistage carcinogenesis in rat liver. Pitot HC; Dragan YP; Teeguarden J; Hsia S; Campbell H Toxicol Pathol; 1996; 24(1):119-28. PubMed ID: 8839289 [TBL] [Abstract][Full Text] [Related]
12. Quantitative stereological evaluation of four histochemical markers of altered foci in multistage hepatocarcinogenesis in the rat. Hendrich S; Campbell HA; Pitot HC Carcinogenesis; 1987 Sep; 8(9):1245-50. PubMed ID: 2887301 [TBL] [Abstract][Full Text] [Related]
13. Critical parameters in the quantitation of the stages of initiation, promotion, and progression in one model of hepatocarcinogenesis in the rat. Pitot HC; Campbell HA; Maronpot R; Bawa N; Rizvi TA; Xu YH; Sargent L; Dragan Y; Pyron M Toxicol Pathol; 1989; 17(4 Pt 1):594-611; discussion 611-2. PubMed ID: 2697939 [TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of vanadium on rat liver carcinogenesis initiated with diethylnitrosamine and promoted by phenobarbital. Bishayee A; Chatterjee M Br J Cancer; 1995 Jun; 71(6):1214-20. PubMed ID: 7779714 [TBL] [Abstract][Full Text] [Related]
15. Expression of c-myc in altered hepatic foci induced in rats by various single doses of diethylnitrosamine and promotion by 0.05% phenobarbital. Deguchi T; Pitot HC Mol Carcinog; 1995 Nov; 14(3):152-9. PubMed ID: 7576107 [TBL] [Abstract][Full Text] [Related]
16. Comparison of hepatocyte phenotypes at the glutathione transferase and albumin loci in Sprague-Dawley and Nagase analbuminemic rats and F1 progeny after initiation and promotion. Dragan YP; Peterson J; Pitot HC Carcinogenesis; 1993 Jul; 14(7):1313-9. PubMed ID: 8330343 [TBL] [Abstract][Full Text] [Related]
17. A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose-response relationships to altered hepatic foci. Pitot HC; Goldsworthy TL; Moran S; Kennan W; Glauert HP; Maronpot RR; Campbell HA Carcinogenesis; 1987 Oct; 8(10):1491-9. PubMed ID: 2888545 [TBL] [Abstract][Full Text] [Related]
18. Tumor promotion as a target for estrogen/antiestrogen effects in rat hepatocarcinogenesis. Dragan YP; Xu YD; Pitot HC Prev Med; 1991 Jan; 20(1):15-26. PubMed ID: 1672562 [TBL] [Abstract][Full Text] [Related]
19. Initiation and promotion of altered hepatic foci in female rats and inhibition of cell-cell communication by the imidazole fungicide prochloraz. Kato Y; Flodström S; Wärngård L Chemosphere; 1998 Aug; 37(3):393-403. PubMed ID: 9661272 [TBL] [Abstract][Full Text] [Related]
20. Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of hepatocarcinogenesis from diethylnitrosamine. Pitot HC; Goldsworthy T; Campbell HA; Poland A Cancer Res; 1980 Oct; 40(10):3616-20. PubMed ID: 6108157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]